Showing results (51-60 of 245) with videos related to
Sort By:
Pageof 25
Neuro-Oncology|August 23, 2011
Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.Bone|October 14, 2003
In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopyRaymond Y Huang, Lisa M Miller, Cathy S Carlson, et al.Current Treatment Options in Neurology|March 10, 2015
How treatment monitoring is influencing treatment decisions in glioblastomasMartha R Neagu, Raymond Y Huang, David A Reardon, et al.Frontiers in Neurology|March 11, 2015
Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining responseRaymond Y Huang, Martha R Neagu, David A Reardon, et al.Neuro-Oncology|August 2, 2022
Artificial intelligence (AI)-based decision support improves reproducibility of tumor response assessment in neuro-oncology: An international multi-reader studyPhilipp Vollmuth, Martha Foltyn, Raymond Y Huang, et al.Neuroimage. Clinical|October 26, 2013
Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imagingDanny J J Wang, Jeffry R Alger, Joe X Qiao, et al.Journal of Neuro-Oncology|December 10, 2013
Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastomaDavis C Woodworth, Whitney B Pope, Linda M Liau, et al.Journal of Magnetic Resonance Imaging : JMRI|January 28, 2012
Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomasBenjamin M Ellingson, Taryar Zaw, Timothy F Cloughesy, et al.Journal of Neuro-Oncology|June 28, 2011
Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumabBenjamin M Ellingson, Timothy F Cloughesy, Albert Lai, et al.Journal of Neuro-Oncology|March 17, 2015
MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Anthony J Hardy, et al.Pageof 25